Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

79.42 -2.44 (-2.98%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lantheus Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Cramer Calls Datadog 'Dynamite,' Puts SoFi In Dog House: 'What The Heck Is Going On'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Marvell Technology, Inc. (NASDAQ: MRVL) reported a mixed quarter. 
Via Benzinga
The 7 Most Undervalued Mid-Cap Stocks to Buy in March 2024
Wager on these top undervalued mid-cap stocks, effectively blending growth and value, with a remarkable broader-market performance in 2023. 
Via InvestorPlace
Investors should take note of NASDAQ:LNTH, a growth stock that remains attractively priced.
Investors seeking growth at a reasonable cost should explore NASDAQ:LNTH. 
Via Chartmill
Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024
From Lantheus Holdings, Inc.
Via GlobeNewswire
NASDAQ:LNTH—A High-Growth Stock Gearing Up for Its Next Upward Move.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH), a strong growth stock, setting up for a breakout. 
Via Chartmill
Assessing Lantheus Holdings: Insights From 4 Financial Analysts
Via Benzinga
Is NASDAQ:LNTH on the Verge of a Major Breakout as a Strong Growth Stock?
Why LANTHEUS HOLDINGS INC (NASDAQ:LNTH) Is a Promising High-Growth Stock in the Midst of Consolidation. 
Via Chartmill
Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients
DEFINITY is the #1 utilized ultrasound enhancing agent in the U.S. for patients with suboptimal echocardiograms 
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Announces Promotion of Amanda Morgan to Chief Commercial Officer
From Lantheus Holdings, Inc.
Via GlobeNewswire
NASDAQ:LNTH is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) appears to be flying under the radar despite its strong fundamentals. 
Via Chartmill
NASDAQ:LNTH is showing good growth, while it is not too expensive.
For those who appreciate growth without the sticker shock, NASDAQ:LNTH is worth considering. 
Via Chartmill
Deep Dive Into Lantheus Holdings Stock: Analyst Perspectives (4 Ratings)
Via Benzinga
Despite its impressive fundamentals, NASDAQ:LNTH remains undervalued.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) is an undervalued gem with solid fundamentals. 
Via Chartmill
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Etsy, Inc. 
Via Benzinga
NICE Posts Upbeat Earnings, Joins FTI Consulting, NVIDIA, Moderna And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Nasdaq Composite gaining more 2% on Thursday. 
Via Benzinga
Topics Stocks
Lantheus Reports Fourth Quarter and Full Year 2023 Financial Results
From Lantheus Holdings, Inc.
Via GlobeNewswire
NASDAQ:LNTH stands out as a growth opportunity that won't break the bank.
While growth is established for LANTHEUS HOLDINGS INC (NASDAQ:LNTH), the stock's valuation remains reasonable. 
Via Chartmill
Lantheus Announces Collaboration to Provide Novel Tau Imaging Agent for Large Consortium Clinical Trial Sponsored by the National Institute on Aging
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus to Host Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast on February 22, 2024, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
Earnings Scheduled For February 22, 2024
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million. 
Via Benzinga
For those who appreciate value investing, NASDAQ:LNTH is a compelling option with its solid fundamentals.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH): good value for what you're paying. 
Via Chartmill
Lantheus Announces CEO Succession Plan
From Lantheus Holdings, Inc.
Via GlobeNewswire
For those who appreciate value investing, NASDAQ:LNTH is a compelling option with its solid fundamentals.
Don't overlook LANTHEUS HOLDINGS INC (NASDAQ:LNTH)—it's a hidden gem with strong fundamentals and an attractive price tag. 
Via Chartmill
Lantheus Announces Acceptance of its First-to-File ANDA for Generic LUTATHERA® (Lutetium Lu 177 Dotatate)
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective Therapeutics
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Reports Preliminary Fiscal Year 2023 Revenue
From Lantheus Holdings, Inc.
Via GlobeNewswire
For those who appreciate growth without the sticker shock, NASDAQ:LNTH is worth considering.
Investors should take note of NASDAQ:LNTH, a growth stock that remains attractively priced. 
Via Chartmill
Lantheus to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Lantheus Holdings, Inc.
Via GlobeNewswire
New Year, New Gains: The 3 Best AI Stocks to Buy in 2024
These AI stocks offer substantial upside potential compared to the overextended chip players that dominated the theme in 2023. 
Via InvestorPlace
Topics Artificial Intelligence
Lantheus Downgraded Due To Reliance On PNT2002; Analyst Cites Comparable Profile To Novartis' Drug
Monday, Lantheus Holdings Inc (NASDAQ: LNTH) and POINT Biopharma Global Inc (NASDAQ: PNT) reported topline data from pivotal Phase 3 SPLASH trial of 177Lu-PNT2002 in metastatic c 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.